Breast oncology encompasses the prevention, diagnosis, molecular characterization, and multidisciplinary treatment of breast cancer across different stages and biological subtypes. This session highlights advances in early and metastatic disease, biomarker-driven treatment, systemic therapies, immunotherapy, surgery, radiation, and long-term management.
Abstract Scope and Participation
Abstracts are welcomed on breast cancer biology, screening, diagnosis, hormone receptor-positive disease, HER2-positive disease, triple-negative breast cancer, metastatic disease, systemic treatment, surgery, radiation, immunotherapy, and survivorship. Clinicians, researchers, surgeons, radiologists, pathologists, and allied specialists are encouraged to contribute.







Title : Long-read sequencing reveals dynamic features of human malignancies
Jianhua Luo, University of Pittsburgh School of Medicine, United States
Title : Nanomedicine in over 45,000 patients and no cancer
Thomas Jay Webster, Brown University, United States